Hormonal regulation of rat adrenomedullin gene in vasculature.

Adrenomedullin (AM), a novel vasodilatory peptide originally isolated from human pheochromocytoma, has subsequently been shown to be expressed in a variety of tissues, such as adrenal gland, lung, heart, kidney, and aorta. To determine whether vascular AM gene expression is under hormonal control, the effects of dexamethasone (DEX) and T3 on AM messenger RNA (mRNA) expression were tested in cultured rat vascular endothelial cells and smooth muscle cells (VSMCs) by Northern blot analysis using polymerase chain reaction-cloned rat AM complementary DNA as a probe. DEX dose and time dependently increased steady-state AM mRNA levels in both endothelial cells and VSMC. T3 modestly induced AM mRNA expression in both cells, whereas rT3, a biologically inactive isomer of T3, failed to affect AM mRNA expression. A glucocorticoid receptor antagonist (RU 38486) blocked DEX-induced AM mRNA expression in both cells, whereas neither estradiol nor testosterone affected AM mRNA expression. Actinomycin D abolished basal as well as stimulated AM mRNA expression by T3, whereas cycloheximide markedly increased steady state mRNA levels (superinduction). The approximate half-lives of basal and stimulated expression of AM mRNA by DEX in VSMC were within 1 h. In contrast, there was little, if any, decay in cycloheximide-induced AM mRNA expression over 6 h. Our study demonstrates that the AM gene expressed by vascular endothelial and smooth muscle cells is similarly regulated by glucocorticoid and possibly by thyroid hormone, and that superinduction of AM mRNA is most likely due to increased mRNA stability.

[1]  S. Heinemann,et al.  Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[2]  N. Minamino,et al.  Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-alpha. , 1994, Biochemical and biophysical research communications.

[3]  K. Miyamoto,et al.  Endothelial cells actively synthesize and secrete adrenomedullin. , 1994, Biochemical and biophysical research communications.

[4]  F. Marumo,et al.  Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells , 1994, FEBS letters.

[5]  K. Kangawa,et al.  Complete amino acid sequence of porcine adrenomedullin and cloning of cDNA encoding its precursor , 1994, FEBS letters.

[6]  F. Marumo,et al.  Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. , 1994, The Journal of clinical investigation.

[7]  F. Marumo,et al.  Cellular mechanism of natriuretic peptides-induced inhibition of endothelin-1 biosynthesis in rat endothelial cells. , 1993, Endocrinology.

[8]  K. Kangawa,et al.  Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. , 1993, Biochemical and biophysical research communications.

[9]  K. Kangawa,et al.  Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. , 1993, Biochemical and biophysical research communications.

[10]  M. Pittelkow,et al.  Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. , 1992, The American journal of physiology.

[11]  K. Nakao,et al.  Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system". , 1992, The Journal of clinical investigation.

[12]  G. Gibbons,et al.  Endothelium and Growth Factors in Vascular Remodeling of Hypertension , 1991, Hypertension.

[13]  F. Collins,et al.  Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. , 1991, Nucleic acids research.

[14]  J. Vane,et al.  Regulatory functions of the vascular endothelium. , 1990, The New England journal of medicine.

[15]  J. Malter,et al.  Identification of an AUUUA-specific messenger RNA binding protein. , 1989, Science.

[16]  R. Evans,et al.  The steroid and thyroid hormone receptor superfamily. , 1988, Science.

[17]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[18]  D. Housman,et al.  Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. , 1987, Science.

[19]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[20]  G. Shaw,et al.  A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation , 1986, Cell.

[21]  B. Beutler,et al.  Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Baxter,et al.  Growth hormone gene transcription is regulated by thyroid and glucocorticoid hormones in cultured rat pituitary tumor cells. , 1982, The Journal of biological chemistry.

[23]  R. Palmiter,et al.  Transcriptional regulation of mouse liver metallothionein-I gene by glucocorticoids , 1981, Nature.

[24]  E. Macarak,et al.  Bovine endothelial cells in culture produce thromboxane as well as prostacyclin. , 1981, The Journal of clinical investigation.

[25]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[26]  J. Vane,et al.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation , 1976, Nature.